Background: Anticoagulant therapy for patients with severe coronavirus disease (COVID-19) pneumonia is considered to improve the hypercoagulable and inflammatory state. However, bleeding complications should also be considered.
Case Presentation: A 77-year-old man with a history of falls was diagnosed with COVID-19.